Opinion|Videos|June 24, 2026

Distinguishing CSU From Chronic Inducible Urticaria Subtypes

In this episode titled “Distinguishing CSU From Chronic Inducible Urticaria Subtypes,” the panel looks at how CSU differs from chronic inducible urticaria (CIndU) and its subtypes. The panelist explains that inducible urticarias have an identifiable physical trigger, the most common being dermatographism, in which scratching, tight clothing, or waistbands provoke hives at the site of pressure. Cold-induced urticaria is another recognizable subtype, often described by patients as hives that appear after re-warming following cold exposure, such as a child breaking out after a chilly soccer practice.

In this episode titled “Distinguishing CSU From Chronic Inducible Urticaria Subtypes,” the panel looks at how CSU differs from chronic inducible urticaria (CIndU) and its subtypes. The panelist explains that inducible urticarias have an identifiable physical trigger, the most common being dermatographism, in which scratching, tight clothing, or waistbands provoke hives at the site of pressure. Cold-induced urticaria is another recognizable subtype, often described by patients as hives that appear after re-warming following cold exposure, such as a child breaking out after a chilly soccer practice.

The panelist stresses that many CSU patients also report a component of dermatographism or other inducible triggers, but this does not change the underlying diagnosis: a patient only qualifies as having a true inducible urticaria if hives occur exclusively with the trigger and never spontaneously. Misclassifying these patients as having an inducible urticaria rather than CSU is a meaningful error, since it unnecessarily limits available treatment options. Published data suggest 10% to 30% of CSU patients also experience concomitant inducible urticaria, meaning clinicians must carefully tease out whether hives ever occur without a trigger before assigning a diagnosis.

The panel agrees that accurately identifying the spontaneous component of a patient’s urticaria, rather than focusing solely on apparent triggers, is essential for ensuring patients are not steered away from the more effective advanced therapies available for CSU. This distinction carries real clinical stakes, since treatment options for a true inducible urticaria remain far more limited than the advanced therapy classes now approved specifically for CSU. Taking the time to clarify whether hives ever truly occur in the absence of a trigger, rather than assuming a label based on the most obvious provoking factor, ultimately determines which treatments a patient can access. In the next episode, “A Practical Diagnostic Workup for CSU,” the panel shares a bedside approach to confirming CSU, differentiating it from urticarial vasculitis, and explaining why extensive lab and allergy testing usually adds little value.


Latest CME